Altshuler Peter J, Bodzin Adam S, Andreoni Kenneth A, Singh Pooja, Yadav Anju, Glorioso Jaime M, Shah Ashesh P, Ramirez Carlo Gerado B, Maley Warren R, Frank Adam M
Department of Surgery, Division of Transplant Surgery, University of California San Francisco, San Francisco, CA.
Department of Surgery, Division of Transplantation, Thomas Jefferson University Hospital, Philadelphia, PA.
Transplant Direct. 2024 Dec 18;11(1):e1744. doi: 10.1097/TXD.0000000000001744. eCollection 2025 Jan.
Deceased donor multiorgan transplants utilizing kidneys (MOTs) can improve outcomes for multiorgan recipients but reduces kidneys for chronic renal failure patients.
We reviewed the Organ Procurement and Transplantation Network database from 2015 through 2019, for adult deceased donor kidney transplants. Recipients were classified as kidney transplant alone (KTA) (n = 62,252) or MOTs pancreas-kidney, simultaneous pancreas-kidney (n = 3,976), liver-kidney, simultaneous liver-kidney (n = 3,212), heart-kidney, simultaneous heart-kidney (n = 808), and "other"-kidney, simultaneous "other" kidney (n = 73).
Liver, heart, and lung-alone transplants were at least 7 times more frequent than their MOT correlate, whereas the inverse was true with pancreas transplantation with SPKs being by far the most common pancreas transplant type. On average, KTA recipients waited between 2.8 and 21.4 times longer than MOTs, with SPKs waiting the longest of the MOT types. Predialysis initiation transplants were less frequent in KTAs compared with MOTs. Use of high-quality grafts according to Kidney Donor Profile Index < 35% was frequent among MOTs, but uncommon in KTAs who had an Estimated Post Transplant Survival score (EPTS) of >20%. For recipients older than 65, SPKs and SOKs were rare, but SLKs and SHKs had a higher fraction of recipients than KTAs and were much more likely to use a Kidney Donor Profile Index <35% kidney. SPKs and KTAs with an EPTS ≤20% had the best kidney graft survival. KTAs with an EPTS ≤80% had better kidney graft survival than SLKs, SHKs, and SOKs.
This study highlights disparities in access to deceased donor kidneys for kidney-alone candidates versus MOTs and suggests opportunities to improve allocation.
利用肾脏进行的已故供体多器官移植(MOTs)可改善多器官受者的结局,但减少了用于慢性肾衰竭患者的肾脏数量。
我们回顾了2015年至2019年器官获取与移植网络数据库中成年已故供体肾脏移植的情况。受者被分为单纯肾脏移植(KTA)(n = 62,252)或多器官移植(MOTs),包括胰肾联合移植、同期胰肾联合移植(n = 3,976)、肝肾联合移植、同期肝肾联合移植(n = 3,212)、心肾联合移植、同期心肾联合移植(n = 808)以及“其他”肾联合移植、同期“其他”肾联合移植(n = 73)。
单独的肝、心和肺移植比其对应的多器官移植至少频繁7倍,而胰肾联合移植(SPK)是迄今为止最常见的胰腺移植类型,情况则相反。平均而言,KTA受者等待的时间比MOTs受者长2.8至21.4倍,其中SPK受者等待时间在MOTs类型中最长。与MOTs相比,KTA中透析前开始移植的情况较少。在MOTs中,根据肾脏供体特征指数<35%使用高质量移植物的情况较为常见,但在移植后估计生存评分(EPTS)>20%的KTA中并不常见。对于65岁以上的受者,SPK和“其他”肾联合移植很少见,但肝肾联合移植(SLK)和心肾联合移植(SHK)的受者比例高于KTA,并且更有可能使用肾脏供体特征指数<35%的肾脏。EPTS≤20%的SPK和KTA的肾移植存活率最高。EPTS≤80%的KTA的肾移植存活率高于SLK、SHK和“其他”肾联合移植。
本研究突出了单纯肾脏移植候选者与多器官移植受者在获取已故供体肾脏方面的差异,并提出了改善分配的机会。